{"id":"https://openalex.org/W2007343514","doi":"https://doi.org/10.1186/1471-2474-15-177","title":"Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study","display_name":"Safety of infusing rituximab at a more rapid rate in patients with rheumatoid arthritis: results from the RATE-RA study","publication_year":2014,"publication_date":"2014-05-24","ids":{"openalex":"https://openalex.org/W2007343514","doi":"https://doi.org/10.1186/1471-2474-15-177","mag":"2007343514","pmid":"https://pubmed.ncbi.nlm.nih.gov/24884454","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4035685"},"language":"en","primary_location":{"id":"doi:10.1186/1471-2474-15-177","doi":"https://doi.org/10.1186/1471-2474-15-177","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2474-15-177","pdf_url":"https://bmcmusculoskeletdisord.biomedcentral.com/counter/pdf/10.1186/1471-2474-15-177","source":{"id":"https://openalex.org/S35439863","display_name":"BMC Musculoskeletal Disorders","issn_l":"1471-2474","issn":["1471-2474"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Musculoskeletal Disorders","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://bmcmusculoskeletdisord.biomedcentral.com/counter/pdf/10.1186/1471-2474-15-177","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"the RATE-RA Study Group","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"the RATE-RA Study Group","raw_affiliation_strings":["Rheumatology Specialty Center, Willow Grove, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology Specialty Center, Willow Grove, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111631743","display_name":"Charles H. Pritchard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Charles H Pritchard","raw_affiliation_strings":["Rheumatology Specialty Center, 2360 Maryland Road, Willow Grove, PA 19090, USA. chas11@verizon.net","Desert Medical Advances, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology Specialty Center, 2360 Maryland Road, Willow Grove, PA 19090, USA. chas11@verizon.net","institution_ids":[]},{"raw_affiliation_string":"Desert Medical Advances, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046072154","display_name":"Maria Greenwald","orcid":"https://orcid.org/0000-0002-2622-1448","observed_orcids":["https://orcid.org/0000-0002-2622-1448"]},"institutions":[{"id":"https://openalex.org/I4210159453","display_name":"Center for Rheumatology","ror":"https://ror.org/04rtaxr13","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210159453"]},{"id":"https://openalex.org/I4405260259","display_name":"Albany Medical College","ror":"https://ror.org/03g66yt05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4405259726","https://openalex.org/I4405260259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maria W Greenwald","raw_affiliation_strings":["Desert Medical Advances, Palm Desert, CA, USA","Albany Medical College and the Center of Rheumatology, Albany, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Desert Medical Advances, Palm Desert, CA, USA","institution_ids":[]},{"raw_affiliation_string":"Albany Medical College and the Center of Rheumatology, Albany, USA","institution_ids":["https://openalex.org/I4210159453","https://openalex.org/I4405260259"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014147030","display_name":"Joel M. Kremer","orcid":"https://orcid.org/0000-0001-6674-9901","observed_orcids":["https://orcid.org/0000-0001-6674-9901"]},"institutions":[{"id":"https://openalex.org/I4210095528","display_name":"Arthritis and Rheumatic Disease Specialties","ror":"https://ror.org/00n3baz54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210095528"]},{"id":"https://openalex.org/I4210159453","display_name":"Center for Rheumatology","ror":"https://ror.org/04rtaxr13","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210159453"]},{"id":"https://openalex.org/I4405260259","display_name":"Albany Medical College","ror":"https://ror.org/03g66yt05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4405259726","https://openalex.org/I4405260259"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joel M Kremer","raw_affiliation_strings":["Albany Medical College and the Center of Rheumatology, Albany, NY, USA","Arthritis & Rheumatic Disease Specialties, Aventura, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Albany Medical College and the Center of Rheumatology, Albany, NY, USA","institution_ids":["https://openalex.org/I4210159453","https://openalex.org/I4405260259"]},{"raw_affiliation_string":"Arthritis & Rheumatic Disease Specialties, Aventura, USA","institution_ids":["https://openalex.org/I4210095528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055224792","display_name":"NORMAN B. GAYLIS","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I107672454","display_name":"Dartmouth College","ror":"https://ror.org/049s0rh22","country_code":"US","type":"education","lineage":["https://openalex.org/I107672454"]},{"id":"https://openalex.org/I4210095528","display_name":"Arthritis and Rheumatic Disease Specialties","ror":"https://ror.org/00n3baz54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210095528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Norman B Gaylis","raw_affiliation_strings":["Arthritis & Rheumatic Disease Specialties, Aventura, FL, USA","Geisel School of Medicine at Dartmouth, Hanover, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arthritis & Rheumatic Disease Specialties, Aventura, FL, USA","institution_ids":["https://openalex.org/I4210095528"]},{"raw_affiliation_string":"Geisel School of Medicine at Dartmouth, Hanover, USA","institution_ids":["https://openalex.org/I107672454"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075200726","display_name":"William F. C. Rigby","orcid":"https://orcid.org/0000-0002-1382-7299","observed_orcids":["https://orcid.org/0000-0002-1382-7299"]},"institutions":[{"id":"https://openalex.org/I107672454","display_name":"Dartmouth College","ror":"https://ror.org/049s0rh22","country_code":"US","type":"education","lineage":["https://openalex.org/I107672454"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Rigby","raw_affiliation_strings":["Geisel School of Medicine at Dartmouth, Hanover, NH, USA","Genentech, Inc, South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Geisel School of Medicine at Dartmouth, Hanover, NH, USA","institution_ids":["https://openalex.org/I107672454"]},{"raw_affiliation_string":"Genentech, Inc, South San Francisco, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067238693","display_name":"Steve Zlotnick","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steve Zlotnick","raw_affiliation_strings":["Genentech, Inc, South San Francisco, CA, USA","Genentech, Inc, South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Genentech, Inc, South San Francisco, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045304205","display_name":"Carol Y. Chung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["CH","US"],"is_corresponding":false,"raw_author_name":"Carol Chung","raw_affiliation_strings":["Genentech, Inc, South San Francisco, CA, USA","F. Hoffmann-La Roche Ltd Basel  Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd Basel  Switzerland","institution_ids":["https://openalex.org/I118019719"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074048075","display_name":"Birgit Jaber","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I118019719","display_name":"F. Hoffmann-La Roche AG","ror":"https://ror.org/00by1q217","country_code":"CH","type":"company","lineage":["https://openalex.org/I118019719"]},{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["CH","US"],"is_corresponding":false,"raw_author_name":"Birgit Jaber","raw_affiliation_strings":["F. Hoffmann-La Roche Ltd, Basel, Switzerland","Genentech, Inc, South San Francisco, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"F. Hoffmann-La Roche Ltd, Basel, Switzerland","institution_ids":["https://openalex.org/I118019719"]},{"raw_affiliation_string":"Genentech, Inc, South San Francisco, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030738776","display_name":"William G. Reiss","orcid":"https://orcid.org/0000-0001-6429-7972","observed_orcids":["https://orcid.org/0000-0001-6429-7972"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William Reiss","raw_affiliation_strings":["Genentech, Inc, South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech, Inc, South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5111631743"],"corresponding_institution_ids":[],"apc_list":{"value":3090,"currency":"USD","value_usd":3090},"apc_paid":{"value":3090,"currency":"USD","value_usd":3090},"fwci":2.4875,"has_fulltext":true,"cited_by_count":34,"citation_normalized_percentile":{"value":0.87610787,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":99},"biblio":{"volume":"15","issue":"1","first_page":"177","last_page":"177"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rheumatoid-arthritis","display_name":"rheumatoid arthritis","score":0.9549999833106995},{"id":"https://openalex.org/keywords/infusion-rate","display_name":"infusion rate","score":0.9259999990463257},{"id":"https://openalex.org/keywords/infusion-related-reactions","display_name":"infusion reactions","score":0.9340000152587891},{"id":"https://openalex.org/keywords/infusion-safety","display_name":"infusion safety","score":0.6119999885559082},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.4350000023841858},{"id":"https://openalex.org/keywords/b-cell-depletion-therapy","display_name":"B-cell depletion therapy","score":0.421999990940094},{"id":"https://openalex.org/keywords/anti-cd20-monoclonal-antibody","display_name":"anti-CD20 monoclonal antibody","score":0.6470000147819519},{"id":"https://openalex.org/keywords/anti-drug-antibodies","display_name":"anti-drug antibodies","score":0.43799999356269836}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9625351428985596},{"id":"https://openalex.org/C2777575956","wikidata":"https://www.wikidata.org/wiki/Q187255","display_name":"Rheumatoid arthritis","level":2,"score":0.8417909741401672},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.8070185780525208},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.6119018793106079},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.5703736543655396},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5216072797775269},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.44856923818588257},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.15891557931900024},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.09169036149978638},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000069283","descriptor_name":"Rituximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001172","descriptor_name":"Arthritis, Rheumatoid","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D018501","descriptor_name":"Antirheumatic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D058846","descriptor_name":"Antibodies, Monoclonal, Murine-Derived","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1186/1471-2474-15-177","doi":"https://doi.org/10.1186/1471-2474-15-177","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2474-15-177","pdf_url":"https://bmcmusculoskeletdisord.biomedcentral.com/counter/pdf/10.1186/1471-2474-15-177","source":{"id":"https://openalex.org/S35439863","display_name":"BMC Musculoskeletal Disorders","issn_l":"1471-2474","issn":["1471-2474"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Musculoskeletal Disorders","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3009407","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4035685","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4035685","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4035685","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Musculoskelet Disord","raw_type":"Text"},{"id":"pmid:24884454","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24884454","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC musculoskeletal disorders","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1186/1471-2474-15-177","doi":"https://doi.org/10.1186/1471-2474-15-177","is_oa":true,"landing_page_url":"https://doi.org/10.1186/1471-2474-15-177","pdf_url":"https://bmcmusculoskeletdisord.biomedcentral.com/counter/pdf/10.1186/1471-2474-15-177","source":{"id":"https://openalex.org/S35439863","display_name":"BMC Musculoskeletal Disorders","issn_l":"1471-2474","issn":["1471-2474"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"BMC Musculoskeletal Disorders","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"},{"id":"https://openalex.org/F4320309432","display_name":"F. Hoffmann-La Roche","ror":"https://ror.org/00by1q217"},{"id":"https://openalex.org/F4320332193","display_name":"Genentech","ror":"https://ror.org/04gndp242"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2007343514.pdf","grobid_xml":"https://content.openalex.org/works/W2007343514.grobid-xml"},"referenced_works_count":13,"referenced_works":["https://openalex.org/W1967735194","https://openalex.org/W2024644107","https://openalex.org/W2038766585","https://openalex.org/W2067117489","https://openalex.org/W2086573607","https://openalex.org/W2094502152","https://openalex.org/W2097020324","https://openalex.org/W2128600935","https://openalex.org/W2141825494","https://openalex.org/W2154645509","https://openalex.org/W2165459235","https://openalex.org/W2313195566","https://openalex.org/W2601826097"],"related_works":["https://openalex.org/W2327328965","https://openalex.org/W1967735194","https://openalex.org/W2313195566","https://openalex.org/W4246568155","https://openalex.org/W2938573360","https://openalex.org/W2232273633","https://openalex.org/W4249676736","https://openalex.org/W4397030521","https://openalex.org/W1499878908","https://openalex.org/W4399438714"],"abstract_inverted_index":{"BACKGROUND:":[0],"As":[1],"recommended":[2],"in":[3,10,59],"the":[4,20,36,43,88,126,182,257,275,280,287],"current":[5],"prescribing":[6],"information,":[7],"rituximab":[8,47,270],"infusions":[9,255,284],"patients":[11,34,60,128,237,249],"with":[12,61,65,121,145,154,169,176,224,233],"rheumatoid":[13],"arthritis":[14],"(RA)":[15],"take":[16],"4.25":[17,90],"hours":[18,25,58],"for":[19,26,52,218],"first":[21],"infusion":[22,54,184,277],"and":[23,35,92,100,131,135,152,173,201,227,282],"3.25":[24],"subsequent":[27,254,283],"infusions,":[28],"which":[29],"is":[30],"a":[31,49,107,239],"burden":[32],"on":[33,251],"health":[37],"care":[38],"system.":[39],"We":[40],"therefore":[41],"evaluated":[42],"safety":[44],"of":[45,56,79,116,142,158,166,241,247,291],"infusing":[46],"at":[48,181,256,274,279],"faster":[50,108,258,276],"rate":[51,185,278,288],"an":[53,66],"period":[55],"2":[57,77,94,228],"RA.":[62],"METHODS:":[63],"Patients":[64],"inadequate":[67],"response":[68],"to":[69,252],"anti-TNF":[70],"who":[71],"were":[72,104,133,212,261],"rituximab-naive":[73,134],"or":[74,215,289],"-experienced":[75],"received":[76,253],"courses":[78],"rituximab:":[80],"Infusion":[81,122,146,225,234],"1":[82,147,214,226],"(Day":[83,95,98,102],"1)":[84],"was":[85,114,148,186],"administered":[86,105,273],"over":[87,106],"standard":[89,183],"hours,":[91],"Infusions":[93,170],"15),":[96],"3":[97,219,221,230,244,246],"168)":[99],"4":[101,174],"182)":[103],"2-hour":[109],"period.":[110],"The":[111,138,162],"primary":[112],"endpoint":[113],"incidence":[115,139,157,163],"infusion-related":[117],"reactions":[118],"(IRRs)":[119],"associated":[120,144,168,223,232],"2.":[123,235],"RESULTS:":[124],"Of":[125],"351":[127],"enrolled,":[129],"87%":[130],"13%":[132],"-experienced,":[136],"respectively.":[137,209],"(95%":[140,164],"CI)":[141,165],"IRRs":[143,167,211,222,231],"16.2%":[149],"(12.5%,":[150],"20.5%)":[151],"consistent":[153],"weighted":[155,178],"historical":[156,179],"20.7%":[159],"(19.4%,":[160],"22.1%).":[161],"2,":[171,216],"3,":[172],"compared":[175],"respective":[177],"incidences":[180],"6.5%":[187],"(4.1%,":[188],"9.7%)":[189],"vs":[190,197,205],"8.1%":[191],"(7.2%,":[192],"9.1%);":[193],"5.9%":[194],"(3.5%,":[195],"9.3%)":[196],"11.5%":[198],"(10.3%,":[199],"12.8%);":[200],"0.7":[202],"(0.1%,":[203],"2.6%)":[204],"5.0%":[206],"(4.2%,":[207],"6.0%),":[208],"All":[210],"grade":[213,220,229,243],"except":[217],"Four":[236],"experienced":[238],"total":[240],"5":[242],"IRRs;":[245],"these":[248],"continued":[250],"rate.":[259],"There":[260],"no":[262],"serious":[263],"IRRs.":[264,292],"CONCLUSION:":[265],"This":[266],"study":[267],"demonstrated":[268],"that":[269],"can":[271],"be":[272],"second":[281],"without":[285],"increasing":[286],"severity":[290]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}